Table 1.
Impact of antidepressants on PSG recorded sleep (according to Riemann and Nissen, 2012 [14])
Types of antidepressantsa | Sleep continuity | Slow wave sleep | REM sleep |
---|---|---|---|
Nonspecific monoamine reuptake inhibitors (TCAs) | |||
Amitriptyline | ↑ | ↔SWS % | ↓ REM %, ↑ REM latency |
Doxepin | ↑ | ↔SWS % | ↓ REM %, ↑ REM latency |
Clomipramine | ↑ | ↑ | ↓ REM % |
Desipramine | ↑ | ↑ | ↓ REM % |
Nortriptyline | ? | ↑ | ↓ REM % |
Imipramine | ? | ? | ↓ REM % |
Selective serotonine reuptake inhibitors (SSRIs) | |||
Citalopram | ? | ? | ↓ |
Fluvoxamine | ↓ | ? | ↓ |
Fluoxetine | ↓ | ? | ↓ |
Paroxetine | ↓ | ? | ↓ |
Noradrenaline reuptake inhibitors (NRIs) | |||
Maprotiline | ↑ | ? | ↓ |
Viloxazine | ↓ | ↓ SWS % | ↓ |
Norepinephrine-dopamine reuptake inhibitors (NDRIs) | |||
Bupropion | ? | ↓ | ↑ |
Serotonine-noradrenaline reuptake inhibitors (SNRIs) | |||
Venlafaxine | ↓ | ? | ↓ REM % |
Monoamine oxidase inhibitors (MAOis) | |||
Moclobemide | ↓ | ? | ↓ REM % |
Phenelzine | ↓ | ? | ↓ REM % |
Other mechanisms of action | |||
Trimipramine | ↑ | ↔SWS % | ↔REM % |
Mirtazapine | ↑ | ↔SWS % | ↔REM % |
Trazodon | ↑ | ↑ SWS % | ↔REM % (↑ to ↓, individual studies) |
aReported effects are based on preponderance of evidence from published studies (see text for details). Many effects are inconsistent between individual studies. “↑” Indicates increase from pre-treatment baseline; “↓” indicates decrease from pre-treatment baseline; “ ↔ ” indicates no change from pre-treatment baseline